Showing results (21-30 of 88) with videos related to
Sort By:
Pageof 9
Journal of Hepatology|March 1, 2011
HIV-induced immune deficiency is associated with a higher risk of hepatocarcinoma, ANRS CO3 Aquitaine Cohort, France, 1998-2008Mathias Bruyand, François Dabis, Marie-Anne Vandenhende, et al.AIDS (London, England)|July 20, 2002
Is hepatitis C virus co-infection associated with survival in HIV-infected patients treated by combination antiretroviral therapy?Corinne Rancinan, Didier Neau, Marianne Savès, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|July 5, 2003
Time-updated CD4+ T lymphocyte count and HIV RNA as major markers of disease progression in naive HIV-1-infected patients treated with a highly active antiretroviral therapy: the Aquitaine cohort, 1996-2001Rodolphe Thiébaut, Geneviève Chêne, Hélène Jacqmin-Gadda, et al.BMC Medical Research Methodology|October 24, 2008
Alternative methods to analyse the impact of HIV mutations on virological response to antiviral therapyLinda Wittkop, Daniel Commenges, Isabelle Pellegrin, et al.AIDS Research and Human Retroviruses|June 28, 2018
A New HIV-1 Circulating Recombinant Form (CRF98_cpx) Between CRF06_cpx and Subtype B Identified in Southwestern FrancePatricia Recordon-Pinson, Brunna M Alves, Camille Tumiotto, et al.JAMA Internal Medicine|April 12, 2016
Long-term Immune Response to Hepatitis B Virus Vaccination Regimens in Adults With Human Immunodeficiency Virus 1: Secondary Analysis of a Randomized Clinical TrialOdile Launay, Arielle R Rosenberg, David Rey, et al.The American Journal of Gastroenterology|September 18, 2008
Validation and comparison of simple noninvasive indexes for predicting liver fibrosis in HIV-HCV-coinfected patients: ANRS CO3 Aquitaine cohortMarc-Arthur Loko, Laurent Castera, François Dabis, et al.Gastroenterologie Clinique Et Biologique|March 28, 2006
Hepatitis B vaccination in HIV-infected patients: a survey of physicians and patients participating in the Aquitaine cohortMaria Winnock, Didier Neau, Laurent Castera, et al.Antimicrobial Agents and Chemotherapy|August 17, 2002
Human immunodeficiency virus type 1 genotypic and pharmacokinetic determinants of the virological response to lopinavir-ritonavir-containing therapy in protease inhibitor-experienced patientsBernard Masquelier, Dominique Breilh, Didier Neau, et al.AIDS Research and Human Retroviruses|December 2, 2011
Molecular characterization of non-B HIV type 1 isolates from patients of a department of infectious diseases, University Hospital of Bordeaux, France, 1989-2009François-Charles Javaugue, Patricia Recordon-Pinson, Madeleine Decoin, et al.Pageof 9